MedTrace Logo

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit

NCT06121115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 473

Last updated 2024-03-12

No results posted yet for this study

Summary

This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes

Conditions

  • Septic Shock
  • Norepinephrine Adverse Reaction
  • Hypotension and Shock

Interventions

DRUG

Norepinephrine

Norepinephrine administered in midline catheter according to clinical routine

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Gustav Torisson, PhD · Region Skåne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121115 on ClinicalTrials.gov